Equibles does not estimate personal net worth.
Get an email with a short summary when MAIA Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get MAIA alertsJoe Visaya has spoken on 1 investor event across 1 company, most recently for MAIA Biotechnology, Inc. on May 21, 2026. MAIA Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MAIA Biotechnology, Inc. includes Vlad Vitoc (CEO), Jeffrey Himmelreich (CFO), Joseph McGuire (CFO) and 7 others.
“The Board of Directors has adopted resolutions which provide this annual meeting to be held today and which fix the close of business on March 23rd, 2026 as the record date for the determination of stockholders entitled to notice of and to vote at this annual meeting.”
Transcript header (unverified)
Biotechnology · Healthcare
